HDAC inhibitor treatment induces a metastatic phenotype in cell lines with p53 gain of function mutations.

被引：0
|
作者：
Montgomery, M. R. [1 ]
Hull, E. E. [1 ]
机构：
[1] Midwestern Univ, Biomed Sci, Glendale, AZ USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1920
引用
收藏
页数：1
相关论文
共 50 条
  • [1] GAIN OF FUNCTION MUTATIONS IN P53
    DITTMER, D
    PATI, S
    ZAMBETTI, G
    CHU, S
    TERESKY, AK
    MOORE, M
    FINLAY, C
    LEVINE, AJ
    NATURE GENETICS, 1993, 4 (01) : 42 - 46
  • [2] Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations
    Kamihira, Shimeru
    Terada, Chiharu
    Sasaki, Daisuke
    Yanagihara, Katsunori
    Tsukasaki, Kunihiro
    Hasegawa, Hiroo
    Yamada, Yasuaki
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (04) : 301 - 307
  • [3] GAIN-OF-FUNCTION MUTATIONS OF THE P53 GENE INDUCE LYMPHOHEMATOPOIETIC METASTATIC POTENTIAL AND TISSUE INVASIVENESS
    HSIAO, M
    LOW, J
    DORN, E
    KU, D
    PATTENGALE, P
    YEARGIN, J
    HAAS, M
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (03): : 702 - 714
  • [4] The MDM2 Inhibitor Nutlin-3 But Not the p53 Activator RITA Induces Loss-of-function p53 Mutations
    Michaelis, M.
    Rothweiler, F.
    Barth, S.
    Cinatl, J.
    van Rikxoort, M.
    von Deimling, A.
    Roedel, F.
    Speidel, D.
    Cinatl, J., Jr.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 43 - 43
  • [5] Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations
    Yan, Wensheng
    Liu, Gang
    Scoumanne, Ariane
    Chen, Xinbin
    CANCER RESEARCH, 2008, 68 (16) : 6789 - 6796
  • [6] Multi-way Restoration of the Function of p53 Oncogenic Mutants by Suppressor Mutations.
    Diskin-Posner, Y.
    Rozenberg, H.
    Diskin-Posner, Y.
    Eldar, A.
    Shakked, Z.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2013, 69 : S318 - S318
  • [7] Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
    Roszkowska, Katarzyna A.
    Gizinski, Slawomir
    Sady, Maria
    Gajewski, Zdzislaw
    Olszewski, Maciej B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [8] Gain-of-function mutations in the tumor suppressor gene p53
    van Oijen, MGCT
    Slootweg, PJ
    CLINICAL CANCER RESEARCH, 2000, 6 (06) : 2138 - 2145
  • [9] HDAC INHIBITION AND GAIN-OF-FUNCTION P53 MUTATION DICTATES ONCOGENIC PHENOTYPE AND INFLUENCES IRON METABOLISM IN THE SW13 CELL LINE
    Montgomery, McKale
    Hull, Elizabeth
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E470 - E470
  • [10] Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression
    Bossi, G
    Lapi, E
    Strano, S
    Rinaldo, C
    Blandino, G
    Sacchi, A
    ONCOGENE, 2006, 25 (02) : 304 - 309
12345